Clinical Trials Arena October 4, 2024
Jenna Philpott

Blood samples from over 500 newborn babies have already been collected across 13 NHS hospitals in England.

England’s National Health Service (NHS) has kick started a study which will screen up to 100,000 newborn babies for over 200 rare diseases.

The Generation Study – led by Genomics England in collaboration with NHS England – will offer whole genome sequencing to newborns using blood samples typically collected from their umbilical cord shortly after birth.

Parents of newborns in England are currently offered a blood spot test when their baby is about five days old. This test, performed with a small heel prick on the baby’s heel, screens for nine rare but serious conditions. However, the genetic sequencing used in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Health System / Hospital, Provider, Trends
Critical Condition: How To Protect The Healthcare Industry From Increasingly Frequent—And Harmful—Cyberattacks
Coalition releases 2024 year-end report
Optimizing the Revenue Cycle Can be Financial Game Changer, KLAS Report Finds
Mount Sinai's grand AI venture
AI, cybersecurity dominate rural healthcare leaders' 2025 agenda

Share This Article